Should I buy Mondelez International (MDLZ) stock or is it too late?
⭐ The most reliable of them, either direction: JP Morgan — 62% of its targets hit on this sector (382 calls tested). It aims for $72 (+17 %), call made on July 30, 2026, maturing on July 30, 2027 (76 d ago).
Firm-by-firm track record on Mondelez International
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| UBS | 88 % | +15.1 % | 8 | $64 +4% |
| Deutsche Bank | 80 % | +6.9 % | 10 | $54 -12% |
| Morgan Stanley | 68 % | +5.5 % | 22 | $70 +14% |
| JP Morgan | 64 % | +4.7 % | 11 | $72 +17% |
| RBC Capital | 62 % | +3.5 % | 8 | $67 +9% |
| Mizuho | 60 % | +2.7 % | 10 | $67 +9% |
| Wells Fargo | 40 % | +1.3 % | 10 | $65 +6% |
| B of A Securities | 71 % | +0.5 % | 7 | $65 +6% |
✅ Reasons to believe
- 86% of analysts rate it a buy (Buy consensus, 7 ratings) — a sign of market conviction.
- Median price target $70, i.e. +14% from the current price ($62).
- The most reliable firm on MDLZ, UBS (88% hit rate, 8 scored calls), targets $64 (call made on April 29, 2026, maturing on April 29, 2027) (+4%) in its most recent call, and $60 (call made on January 14, 2026, maturing on January 14, 2027) (-2%) in the one coming due soonest.
- Pays a dividend (3.4% yield), raised for 11 years — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 7 ratings, 1 is neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on MDLZ
Median target $70 (+14%) · 7 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Mondelez International now?
We won't decide for you. The facts: 86% of analysts rate it a buy, median target $70 (+14%), and UBS (most reliable on MDLZ, 88%) targets $64. Weigh that against valuation (P/E ~23). This is not personalized advice.
Is it too late to invest in Mondelez International?
Not according to analysts: the median target ($70) is still +14% above the current price ($62) (most reliable on MDLZ: UBS, 88%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Mondelez International still worth investing in?
It depends on the gap between the price ($62) and its estimated value: analysts target $70 on median (+14%), with 86% buys (most reliable on MDLZ: UBS, 88%). Cross-check with their real reliability on MDLZ and the cautions above. Information, not advice.
What's the main risk in buying MDLZ?
The consensus is not unanimous: of 7 ratings, 1 is neutral.
→ Go deeper: the full Mondelez International profile (consensus, analyst reliability, price target, performance).